Table 4 QoL in the two studied groups before injection
MTP group ( N = 45) | TMC group ( N = 45) | Test of significance | p -value | |||
|---|---|---|---|---|---|---|
Mobility | ||||||
No problems | 5 | 11.1% | 5 | 11.1% | Χ 2 = 0.296 | 0.990 |
Slight problems | 9 | 20% | 9 | 20% | ||
Moderate problems | 9 | 20% | 10 | 22.2% | ||
Severe problems | 11 | 24.4% | 9 | 20% | ||
Extreme problems | 11 | 24.4% | 12 | 26.7% | ||
Self-care | ||||||
No problems | 10 | 22.2% | 11 | 24.4% | MC = 1.377 | 0.848 |
Slight problems | 7 | 15.6% | 10 | 22.2% | ||
Moderate problems | 15 | 33.3% | 12 | 26.7% | ||
Severe problems | 7 | 15.6% | 8 | 17.8% | ||
Extreme problems | 6 | 13.3% | 4 | 8.9% | ||
Usual activities | ||||||
No problems | 6 | 13.3% | 7 | 15.5% | Χ 2 = 0.457 | 0.978 |
Slight problems | 10 | 22.2% | 8 | 17.8% | ||
Moderate problems | 11 | 24.4% | 10 | 22.2% | ||
Severe problems | 11 | 24.4% | 12 | 26.7% | ||
Extreme problems | 7 | 15.5% | 8 | 17.8% | ||
Pain/discomfort | ||||||
No problems | 3 | 6.7% | 3 | 6.7% | MC = 0.820 | 0.963 |
Slight problems | 6 | 13.3% | 5 | 11.1% | ||
Moderate problems | 7 | 15.6% | 10 | 22.2% | ||
Severe problems | 18 | 40% | 18 | 40% | ||
Extreme problems | 11 | 24.4% | 9 | 20% | ||
Anxiety depression | ||||||
No problems | 4 | 8.9% | 1 | 2.2% | MC = 2.528 | 0.640 |
Slight problems | 8 | 17.8% | 6 | 13.3% | ||
Moderate problems | 15 | 33.3% | 16 | 35.6% | ||
Severe problems | 12 | 26.7% | 15 | 33.3% | ||
Extreme problems | 6 | 13.3% | 7 | 15.6% | ||